Wikidata

(Q66059163)

English

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

clinical trial

In more languages

Statements

short name
STRIDE-PD (English)
0 references
title
A Long Term, Double-blind, Randomized, Parallel-group, Carbidopa/Levodopa Controlled, Multi-center Study to Evaluate the Effect of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy (English)
0 references
sponsor
Novartis
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Italy
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Turkey
0 references
United Kingdom
0 references
start time
September 2004
0 references
end time
November 2008
0 references
number of participants
747
0 references
minimum age
30 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66059163&oldid=1858691363"